BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsHighPositive
Announced Tue, 2 Jun, 2026 · 19:38 IST

WHO-GMP Compliance Confirmed for Palghar Manufacturing Facility

Regulatory Product ApprovalBusiness Updates View source PDFExplain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹435.95
prior close
₹438.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.3-0.1+0.7+4.0+0.4-3.3-3.4-2.9+0.2+5.7+15.6+6.2+46.1
Up moveDown movePending
AI summary

Bliss GVS Pharma's manufacturing facility at Survey No 43 and 44, Vevoor Village, Palghar (East), Maharashtra has received an Inspection Closure Report from WHO Geneva confirming compliance with WHO Good Manufacturing Practices (GMP) standards. The company says this reflects its commitment to quality assurance, safety and operational excellence. WHO-GMP certification is a key regulatory milestone that enables the company to supply pharmaceutical products to global markets and UN agencies.

Likely market impact

Positive for long-term growth. WHO-GMP compliance strengthens global credibility and opens access to international and UN agency procurement markets.